Mutual of America Capital Management LLC decreased its holdings in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 14.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,438 shares of the company’s stock after selling 4,435 shares during the period. Mutual of America Capital Management LLC owned 0.05% of Azenta worth $1,281,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in AZTA. Dimensional Fund Advisors LP boosted its stake in Azenta by 16.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after purchasing an additional 421,719 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Azenta by 16.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock worth $62,917,000 after buying an additional 183,040 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its position in shares of Azenta by 1.9% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after acquiring an additional 100,826 shares during the last quarter. Squarepoint Ops LLC grew its stake in Azenta by 433.6% during the second quarter. Squarepoint Ops LLC now owns 73,055 shares of the company’s stock valued at $3,844,000 after acquiring an additional 59,364 shares in the last quarter. Finally, Royce & Associates LP increased its holdings in Azenta by 7.8% in the 3rd quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock valued at $35,844,000 after acquiring an additional 53,584 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.
Insider Activity at Azenta
In other news, Director William L. Cornog purchased 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The shares were bought at an average cost of $39.60 per share, for a total transaction of $495,000.00. Following the acquisition, the director now owns 14,755 shares of the company’s stock, valued at approximately $584,298. This trade represents a 554.32 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO John Marotta acquired 12,717 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was purchased at an average cost of $39.48 per share, with a total value of $502,067.16. Following the purchase, the chief executive officer now owns 99,612 shares of the company’s stock, valued at $3,932,681.76. The trade was a 14.63 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have sold 3,018 shares of company stock worth $126,689. Company insiders own 1.77% of the company’s stock.
Azenta Stock Up 0.9 %
Azenta (NASDAQ:AZTA – Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.08. The company had revenue of $170.00 million for the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.13 earnings per share. As a group, sell-side analysts expect that Azenta, Inc. will post 0.4 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of brokerages have recently weighed in on AZTA. Needham & Company LLC cut their price objective on Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Evercore ISI dropped their price target on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research note on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $63.60.
Read Our Latest Analysis on AZTA
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More
- Five stocks we like better than Azenta
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- The How And Why of Investing in Oil Stocks
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What Does Downgrade Mean in Investing?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.